Company Filing History:
Years Active: 2006-2008
Title: David G Atkins: Innovator in Biochemical Research
Introduction
David G Atkins is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biochemical research, holding a total of 3 patents. His work primarily focuses on the development of innovative solutions in molecular biology.
Latest Patents
Among his latest patents, one invention involves catalytic molecules. This invention relates to DNAzymes that target mRNA molecules encoding EGR-1, also known as Egr-1 and NGFI-A. The invention includes compositions featuring these DNAzymes and methods of treatment that involve their administration. Another significant patent concerns codeinone reductase derived from alkaloid poppy plants. This invention encompasses the polynucleotides encoding the enzyme, transgenic plants transformed with these polynucleotides, and the production of alkaloids from the transformed poppy plants.
Career Highlights
David G Atkins has worked with prominent companies in the research sector, including Johnson & Johnson Research Pty Limited and Unisearch Limited. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Toni M Kutchan and Anthony John Fist. These partnerships have further enriched his research and development efforts.
Conclusion
David G Atkins stands out as a significant figure in biochemical innovation, with a focus on developing groundbreaking solutions in molecular biology. His contributions continue to impact the field positively.